Unknown

Dataset Information

0

Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbation.


ABSTRACT: Rhinovirus (RV) infections are associated with asthma exacerbations. MicroRNA-146a and microRNA-146b (miR-146a/b) are anti-inflammatory miRNAs that suppress signaling through the nuclear factor kappa B (NF-κB) pathway and inhibit pro-inflammatory chemokine production in primary human bronchial epithelial cells (HBECs). In the current study, we aimed to explore whether miR-146a/b could regulate cellular responses to RVs in HBECs and airways during RV-induced asthma exacerbation. We demonstrated that expression of miR-146a/b and pro-inflammatory chemokines was increased in HBECs and mouse airways during RV infection. However, transfection with cell-penetrating peptide (CPP)-miR-146a nanocomplexes before infection with RV significantly reduced the expression of the pro-inflammatory chemokines CCL5, IL-8 and CXCL1, increased interferon-λ production, and attenuated infection with the green fluorescent protein (GFP)-expressing RV-A16 in HBECs. Concordantly, compared to wild-type (wt) mice, Mir146a/b-/- mice exhibited more severe airway neutrophilia and increased T helper (Th)1 and Th17 cell infiltration in response to RV-A1b infection and a stronger Th17 response with a less prominent Th2 response in house dust mite extract (HDM)-induced allergic airway inflammation and RV-induced exacerbation models. Interestingly, intranasal administration of CPP-miR-146a nanocomplexes reduced HDM-induced allergic airway inflammation without a significant effect on the Th2/Th1/Th17 balance in wild-type mice. In conclusion, the overexpression of miR-146a has a strong anti-inflammatory effect on RV infection in HBECs and a mouse model of allergic airway inflammation, while a lack of miR-146a/b leads to attenuated type 2 cell responses in mouse models of allergic airway inflammation and RV-induced exacerbation of allergic airway inflammation. Furthermore, our data indicate that the application of CPP-miR-146a nanocomplexes has therapeutic potential for targeting airway inflammation.

SUBMITTER: Laanesoo A 

PROVIDER: S-EPMC8161513 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3384678 | biostudies-literature
| S-EPMC4246061 | biostudies-literature
| S-EPMC3208645 | biostudies-literature
| S-EPMC5821220 | biostudies-literature
| S-EPMC8379077 | biostudies-literature
| S-EPMC4863152 | biostudies-literature
| S-EPMC4042510 | biostudies-literature
| S-EPMC4725057 | biostudies-literature
| S-EPMC3284547 | biostudies-literature
| S-EPMC6815837 | biostudies-literature